1. Home
  2. GOSS vs IBEX Comparison

GOSS vs IBEX Comparison

Compare GOSS & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • IBEX
  • Stock Information
  • Founded
  • GOSS 2015
  • IBEX 2017
  • Country
  • GOSS United States
  • IBEX United States
  • Employees
  • GOSS N/A
  • IBEX N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • IBEX EDP Services
  • Sector
  • GOSS Health Care
  • IBEX Technology
  • Exchange
  • GOSS Nasdaq
  • IBEX Nasdaq
  • Market Cap
  • GOSS 347.8M
  • IBEX 386.9M
  • IPO Year
  • GOSS 2019
  • IBEX 2020
  • Fundamental
  • Price
  • GOSS $2.47
  • IBEX $29.53
  • Analyst Decision
  • GOSS Strong Buy
  • IBEX Hold
  • Analyst Count
  • GOSS 4
  • IBEX 2
  • Target Price
  • GOSS $8.50
  • IBEX $27.00
  • AVG Volume (30 Days)
  • GOSS 3.1M
  • IBEX 83.2K
  • Earning Date
  • GOSS 08-05-2025
  • IBEX 09-11-2025
  • Dividend Yield
  • GOSS N/A
  • IBEX N/A
  • EPS Growth
  • GOSS N/A
  • IBEX 48.53
  • EPS
  • GOSS N/A
  • IBEX 2.25
  • Revenue
  • GOSS $40,237,000.00
  • IBEX $535,666,000.00
  • Revenue This Year
  • GOSS N/A
  • IBEX $9.12
  • Revenue Next Year
  • GOSS $30.65
  • IBEX $5.80
  • P/E Ratio
  • GOSS N/A
  • IBEX $13.11
  • Revenue Growth
  • GOSS N/A
  • IBEX 5.35
  • 52 Week Low
  • GOSS $0.66
  • IBEX $16.35
  • 52 Week High
  • GOSS $2.65
  • IBEX $32.08
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 68.08
  • IBEX 53.17
  • Support Level
  • GOSS $2.38
  • IBEX $28.99
  • Resistance Level
  • GOSS $2.65
  • IBEX $30.34
  • Average True Range (ATR)
  • GOSS 0.15
  • IBEX 0.75
  • MACD
  • GOSS 0.03
  • IBEX 0.08
  • Stochastic Oscillator
  • GOSS 76.67
  • IBEX 61.06

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

Share on Social Networks: